Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Seirafi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Revue Medicale Suisse|October 7, 2009
[Cirrhotic cardiomyopathy]M Seirafi, L Spahr
Revue Medicale Suisse|November 21, 2007
[Acetaminophen: hepatotoxicity at therapeutic doses and risk factors]M Seirafi, A Iten, A Hadengue
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|July 8, 2011
[Inflammatory bowel diseases: gynecological and obstetrical considerations]P Amate, M Seirafi, Y Bouhnik, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|July 8, 2011
[Anti-TNFα therapy and its implication in gynecology and obstetrics]G Ducarme, P Amate, M Seirafi, et al.
Swiss Medical Weekly|December 20, 2011
No need to search for the source of haematogenous arthroplasty infectionsC Bouvet, D Tchernin, M Seirafi, et al.
Alimentary Pharmacology & Therapeutics|July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel diseaseM Seirafi, B de Vroey, A Amiot, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Revue Medicale Suisse|October 7, 2009
[Cirrhotic cardiomyopathy]M Seirafi, L Spahr
Revue Medicale Suisse|November 21, 2007
[Acetaminophen: hepatotoxicity at therapeutic doses and risk factors]M Seirafi, A Iten, A Hadengue
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|July 8, 2011
[Inflammatory bowel diseases: gynecological and obstetrical considerations]P Amate, M Seirafi, Y Bouhnik, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|July 8, 2011
[Anti-TNFα therapy and its implication in gynecology and obstetrics]G Ducarme, P Amate, M Seirafi, et al.
Swiss Medical Weekly|December 20, 2011
No need to search for the source of haematogenous arthroplasty infectionsC Bouvet, D Tchernin, M Seirafi, et al.
Alimentary Pharmacology & Therapeutics|July 2, 2014
Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel diseaseM Seirafi, B de Vroey, A Amiot, et al.
Pageof 1